ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Biophytis

Biophytis (ALBPS)

0.4202
-0.0097
(-2.26%)
終了 1月6日 1:30AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.4202
買値
0.4203
売値
0.43
出来高
32,457
0.415 日の範囲 0.4349
0.0021 52 週間の範囲 1.40
時価総額
前日終値
0.4299
始値
0.432
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
39,574
発行済株式数
295,702,507
配当利回り
-
PER
-7.29
1 株当たり利益 (EPS)
-0.06
歳入
-
純利益
-17.03M

Biophytis について

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Paris, Paris, Fra
設立
-
Biophytis is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker ALBPS. The last closing price for Biophytis was 0.43 €. Over the last year, Biophytis shares have traded in a share price range of 0.0021 € to 1.40 €.

Biophytis currently has 295,702,507 shares in issue. The market capitalisation of Biophytis is 127.12 € million. Biophytis has a price to earnings ratio (PE ratio) of -7.29.

ALBPS 最新ニュース

Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a clinical-stage biotechnology company...

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company specialized in the development of drug...

Biophytis Announces Results of 2019 Annual General Meeting of Shareholders

All resolutions within the competence of the Ordinary General Meeting adoptedSecond notice to reconvene the Extraordinary General Meeting to be held in the coming weeks PARIS and CAMBRIDGE...

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)

Provides funding for additional preclinical experiments and for the MYODA preparations for the clinical study in Duchenne muscular dystrophy (DMD) PARIS and CAMBRIDGE, Mass., June 13, 2019...

Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer

PARIS and CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

Biophytis Announces Publication of its 2018 Annual Report

Files 2018 Annual Report with the AMFProvides first quarter 2019 financial statementsEnters into intellectual property agreement with Stanislas Veillet PARIS and CAMBRIDGE, Mass., May 22, 2019...

Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States

PARIS and CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopeniaLaunch of our MYODA program for Duchenne muscular dystrophy...

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

PARIS, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of novel therapeutics for age-related...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.070220.05714285710.350.4350.34487330.39755111DE
40.105233.39682539680.3150.4350.3294550.35522219DE
120.075121.76180817150.34510.4350.28395740.3235611DE
26-0.1898-31.11475409840.610.840.28473430.46943653DE
520.41497828.301886790.00531.40.002162658790.00606944DE
156-0.0539-11.36890951280.47411.40.002154605670.0283445DE
2600.2152104.9756097560.2052.730.002147276900.27490258DE

ALBPS - Frequently Asked Questions (FAQ)

What is the current Biophytis share price?
The current share price of Biophytis is 0.4202 €
How many Biophytis shares are in issue?
Biophytis has 295,702,507 shares in issue
What is the market cap of Biophytis?
The market capitalisation of Biophytis is EUR 127.12M
What is the 1 year trading range for Biophytis share price?
Biophytis has traded in the range of 0.0021 € to 1.40 € during the past year
What is the PE ratio of Biophytis?
The price to earnings ratio of Biophytis is -7.29
What is the reporting currency for Biophytis?
Biophytis reports financial results in EUR
What is the latest annual profit for Biophytis?
The latest annual profit of Biophytis is EUR -17.03M
What is the registered address of Biophytis?
The registered address for Biophytis is 14 AVENUE DE L’OPERA, PARIS, PARIS, 75001
What is the Biophytis website address?
The website address for Biophytis is www.biophytis.com
Which industry sector does Biophytis operate in?
Biophytis operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M